Forsta AP Fonden Reduces Position in Xylem Inc. $XYL

Forsta AP Fonden trimmed its stake in Xylem Inc. (NYSE:XYL) by 18.5% in the second quarter, HoldingsChannel.com reports. The fund owned 86,700 shares of the industrial products company’s stock after selling 19,700 shares during the quarter. Forsta AP Fonden’s holdings in Xylem were worth $11,216,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Maseco LLP purchased a new stake in Xylem during the 2nd quarter worth about $31,000. ST Germain D J Co. Inc. boosted its stake in shares of Xylem by 950.0% during the 2nd quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company’s stock worth $33,000 after purchasing an additional 228 shares during the last quarter. Headlands Technologies LLC grew its holdings in shares of Xylem by 90.6% during the first quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company’s stock worth $36,000 after buying an additional 145 shares in the last quarter. Signature Resources Capital Management LLC purchased a new stake in shares of Xylem during the second quarter worth about $39,000. Finally, Zions Bancorporation National Association UT acquired a new position in shares of Xylem in the first quarter valued at approximately $40,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Stock Down 1.6%

Shares of NYSE XYL opened at $147.48 on Friday. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $154.27. The firm has a fifty day moving average of $146.13 and a 200-day moving average of $136.60. The stock has a market capitalization of $35.91 billion, a PE ratio of 37.91, a P/E/G ratio of 2.50 and a beta of 1.15. The company has a quick ratio of 1.43, a current ratio of 1.96 and a debt-to-equity ratio of 0.17.

Xylem (NYSE:XYL) last issued its earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.23 by $0.14. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The business had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.22 billion. During the same period last year, the company posted $1.11 EPS. The business’s quarterly revenue was up 7.8% on a year-over-year basis. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, analysts anticipate that Xylem Inc. will post 4.65 EPS for the current year.

Insider Transactions at Xylem

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction dated Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the transaction, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at $413,861.72. The trade was a 25.27% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Victoria D. Harker sold 1,700 shares of the business’s stock in a transaction dated Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total value of $251,838.00. Following the sale, the director owned 16,875 shares of the company’s stock, valued at $2,499,862.50. The trade was a 9.15% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 13,121 shares of company stock worth $1,982,459 in the last three months. 0.27% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

XYL has been the topic of a number of analyst reports. Wall Street Zen upgraded shares of Xylem from a “hold” rating to a “buy” rating in a research report on Saturday, August 9th. UBS Group increased their price target on Xylem from $168.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, November 6th. Cowen reaffirmed a “hold” rating on shares of Xylem in a research report on Tuesday, August 26th. TD Cowen upped their target price on Xylem from $125.00 to $130.00 and gave the company a “hold” rating in a research note on Tuesday, August 26th. Finally, Citigroup increased their target price on Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, Xylem presently has an average rating of “Moderate Buy” and a consensus price target of $166.90.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.